Validation of a frailty index in patients undergoing curative surgery for urologic malignancy and comparison with other risk stratification tools
详细信息 查看全文
- 作者：Danny Lascano ; B.A.a ; dl2178@columbia.edu" class="auth_mail" title="E-mail the corresponding author ; dlascan1@gmail.com" class="auth_mail" title="E-mail the corresponding author ; Jamie S. Pak ; B.A.a ; Max Kates ; M.D.b ; Julia B. Finkelstein ; M.D.a ; Mark Silva ; M.D.a ; Elizabeth Hagen ; B.A.a ; Arindam RoyChoudhury ; Ph.D.c ; Trinity J. Bivalacqua ; M.D. ; Ph.D.b ; G. Joel DeCastro ; M.D. ; M.P.H.a ; Mitchell C. Benson ; M.D.a ; James M. McKiernan ; M.D.a
- 关键词：Frail elderly ; Surgical outcomes ; Urologic oncology ; Preoperative evaluation ; Patient survival
- 刊名：Urologic Oncology: Seminars and Original Investigations
- 出版年：2015
- 出版时间：October 2015
- 年：2015
- 卷：33
- 期：10
- 页码：426.e1-426.e12
- 全文大小：1801 K
文摘
- •
Compared and validated a frailty index to existing risk stratification tools for urologic surgery.
- •
Examined whether our modified frailty index was predictive of death and complications.
- •
Increasingly frailty patients with high frailty index scores have adverse outcomes.
- •
Combining the ASA Risk Class and our modified frailty index was the best predictor of adverse events
- •
A modified frailty index may help risk stratify patients who are not good surgical candidates.